195 related articles for article (PubMed ID: 11404286)
1. Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice.
Samuels SE; Knowles AL; Tilignac T; Debiton E; Madelmont JC; Attaix D
Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R133-9. PubMed ID: 11404286
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
Tilignac T; Temparis S; Combaret L; Taillandier D; Pouch MN; Cervek M; Cardenas DM; Le Bricon T; Debiton E; Samuels SE; Madelmont JC; Attaix D
Cancer Res; 2002 May; 62(10):2771-7. PubMed ID: 12019153
[TBL] [Abstract][Full Text] [Related]
3. Protein metabolism in the small intestine during cancer cachexia and chemotherapy in mice.
Samuels SE; Knowles AL; Tilignac T; Debiton E; Madelmont JC; Attaix D
Cancer Res; 2000 Sep; 60(17):4968-74. PubMed ID: 10987314
[TBL] [Abstract][Full Text] [Related]
4. Liver protein synthesis stays elevated after chemotherapy in tumour-bearing mice.
Samuels SE; McLaren TA; Knowles AL; Stewart SA; Madelmont JC; Attaix D
Cancer Lett; 2006 Jul; 239(1):78-83. PubMed ID: 16140458
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
6. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Guo D; Wang C; Wang Q; Qiao Z; Tang H
Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
[TBL] [Abstract][Full Text] [Related]
7. Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.
Hardee JP; Montalvo RN; Carson JA
Oxid Med Cell Longev; 2017; 2017():8018197. PubMed ID: 29375734
[TBL] [Abstract][Full Text] [Related]
8. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.
Lautaoja JH; Lalowski M; Nissinen TA; Hentilä J; Shi Y; Ritvos O; Cheng S; Hulmi JJ
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E852-E865. PubMed ID: 30860875
[TBL] [Abstract][Full Text] [Related]
9. Effect of tumor burden and subsequent surgical resection on skeletal muscle mass and protein turnover in colorectal cancer patients.
Williams JP; Phillips BE; Smith K; Atherton PJ; Rankin D; Selby AL; Liptrot S; Lund J; Larvin M; Rennie MJ
Am J Clin Nutr; 2012 Nov; 96(5):1064-70. PubMed ID: 23034966
[TBL] [Abstract][Full Text] [Related]
10. Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice.
Salazar-Degracia A; Granado-Martínez P; Millán-Sánchez A; Tang J; Pons-Carreto A; Barreiro E
J Cell Physiol; 2019 Aug; 234(10):18041-18052. PubMed ID: 30851071
[TBL] [Abstract][Full Text] [Related]
11. Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia.
Smith KL; Tisdale MJ
Br J Cancer; 1993 Apr; 67(4):680-5. PubMed ID: 8471425
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
13. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
14. An Immune-Modulating Diet in Combination with Chemotherapy Prevents Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice.
Nakamura K; Sasayama A; Takahashi T; Yamaji T
Nutr Cancer; 2015; 67(6):912-20. PubMed ID: 26133950
[TBL] [Abstract][Full Text] [Related]
15. Myocardial dysfunction in an animal model of cancer cachexia.
Xu H; Crawford D; Hutchinson KR; Youtz DJ; Lucchesi PA; Velten M; McCarthy DO; Wold LE
Life Sci; 2011 Feb; 88(9-10):406-10. PubMed ID: 21167183
[TBL] [Abstract][Full Text] [Related]
16. Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover.
Dworzak F; Ferrari P; Gavazzi C; Maiorana C; Bozzetti F
Cancer; 1998 Jan; 82(1):42-8. PubMed ID: 9428478
[TBL] [Abstract][Full Text] [Related]
17. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
18. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.
Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
Dis Model Mech; 2012 Jul; 5(4):533-45. PubMed ID: 22563056
[TBL] [Abstract][Full Text] [Related]
19. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of skeletal muscle myosin isoforms in cancer cachexia.
Diffee GM; Kalfas K; Al-Majid S; McCarthy DO
Am J Physiol Cell Physiol; 2002 Nov; 283(5):C1376-82. PubMed ID: 12372798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
